Whether you choose to donate, volunteer, or fundraise, you’ll become a Lime Champion, joining our vibrant community to raise awareness about lymphoma and support patients throughout their journey.
Your efforts directly impact the 7,400 Australians diagnosed each year — that’s one person every two hours — by helping ensure our Specialist Lymphoma Care Nurses can continue providing crucial support and services to patients and their families.
Fundraise to help make a lasting impact on the lives of people diagnosed with lymphoma.
Join the lime community and volunteer with us.
Raise awareness about lymphoma and CLL, and provide inspiration and comfort to others facing similar challenges.
Become a corporate partner of Lymphoma Australia and support patients throughout their entire lymphoma journey.
Click here to raise awareness about lymphoma and CLL, and provide inspiration and comfort to others facing similar challenges.
Click here to raise awareness about lymphoma and CLL, and provide inspiration and comfort to others facing similar challenges.
Your generous donation today will have a profound impact on lymphoma patients and their families. It ensures access to vital services such as lymphoma care nurses, essential resources, and support programs.
Donations to Lymphoma Australia over $2.00 are tax deductible.
Lymphoma Australia is a registered charity with DGR-1 status.
ABN number – 36 709 461 048
Please note: Lymphoma Australia staff are only able to reply to emails sent in English language.
For people living in Australia, we can offer a phone translation service. Have your nurse or English speaking relative call us to arrange this.
You need healthy T-cells to make CAR T-cells. For this reason, CAR T-cell therapy cannot be used if you have a T-cell lymphoma – yet.
For more information on CAR T-cells and T-cell lymphoma click here.
Special Note: Although your T-cells are removed from your blood for CAR T-cell therapy, most of our T-cells live outside of our blood – in our lymph nodes, thymus, spleen and other organs.
